IDX:MEDS Income Statement

Financials in millions IDR. Fiscal year is January - December.

Millions IDR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	4,582	6,391	22,723	37,737	75,790	87,790
Revenue Growth (YoY)	-73.50%	-71.88%	-39.79%	-50.21%	-13.67%	630.26%
Cost of Revenue	5,122	5,866	12,086	16,712	21,812	29,182
Gross Profit	-539.51	525.3	10,637	21,025	53,978	58,607
Selling, General & Admin	8,625	9,199	13,240	16,472	19,914	9,968
Operating Expenses	8,625	9,199	13,240	16,472	19,914	9,968
Operating Income	-9,164	-8,674	-2,603	4,553	34,064	48,639
Interest Expense	-561.16	-482.4	-663.42	-759.2	-180.42	-10.1
Interest & Investment Income	0.9	0.82	2.85	24.42	233.16	23.01
Other Non Operating Income (Expenses)	1,246	881.55	-323.87	-3,222	10.95	37.31
Pretax Income	-8,478	-8,274	-3,587	596.32	34,128	48,690
Income Tax Expense	263.36	259.95	-17.01	359.25	7,496	10,727
Net Income	-8,742	-8,534	-3,570	237.06	26,631	37,962
Net Income to Common	-8,742	-8,534	-3,570	237.06	26,631	37,962
Net Income Growth	-	-	-	-99.11%	-29.85%	12208.88%
Shares Outstanding (Basic)	1,563	1,563	1,563	1,373	1,250	1,250
Shares Outstanding (Diluted)	1,563	1,563	1,563	1,373	1,250	1,250
Shares Change (YoY)	-	-	13.78%	9.86%	-	17.63%
EPS (Basic)	-5.59	-5.46	-2.29	0.17	21.31	30.37
EPS (Diluted)	-5.59	-5.46	-2.29	0.17	21.31	30.37
EPS Growth	-	-	-	-99.19%	-29.85%	10363.81%
Free Cash Flow	-3,301	1,954	-2,932	-30,995	-13,524	41,305
Free Cash Flow Per Share	-2.11	1.25	-1.88	-22.57	-10.82	33.04
Gross Margin	-11.77%	8.22%	46.81%	55.71%	71.22%	66.76%
Operating Margin	-200.01%	-135.72%	-11.46%	12.07%	44.95%	55.40%
Profit Margin	-190.78%	-133.52%	-15.71%	0.63%	35.14%	43.24%
Free Cash Flow Margin	-72.04%	30.58%	-12.90%	-82.13%	-17.84%	47.05%
EBITDA	-5,092	-4,472	985.21	7,254	35,591	49,202
EBITDA Margin	-111.14%	-69.97%	4.34%	19.22%	46.96%	56.05%
D&A For EBITDA	4,072	4,202	3,588	2,701	1,527	562.22
EBIT	-9,164	-8,674	-2,603	4,553	34,064	48,639
EBIT Margin	-200.01%	-135.72%	-11.46%	12.07%	44.95%	55.40%
Effective Tax Rate	-	-	-	60.25%	21.96%	22.03%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.